Development of Sustained Release Tablet containing Antidiabetic Agent | DealShopping Deutschland
  1. Home
  2. Medien
  3. Bücher
  4. Development of Sustained Release Tablet containing Antidiabetic Agent
  • #
  • #

Development of Sustained Release Tablet containing Antidiabetic Agent

223.60 EUR 54.90 EUR 75% Off

Teilen:

Ähnliche Produkte

Development of Carvedilol Phosphate sustained release tablet: Anti-hypertensive agent:Carvedilol phosphate

Development of Carvedilol Phosphate sustained release tablet: Anti-hypertensive agent:Carvedilol phosphate

59.00 EUR
Development and optimization of naproxen sustained release tablets

Development and optimization of naproxen sustained release tablets

61.90 EUR
Sustained Release Tablet of Itopride Hydrochloride: Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery

Sustained Release Tablet of Itopride Hydrochloride: Formulation, Development and In Vitro Evaluation Reduce Dosing Frequency by Once a Day Delivery

236.00 EUR
Sustained Release Pellets of Ambroxol Hydrochloride: Development and in vitro Study

Sustained Release Pellets of Ambroxol Hydrochloride: Development and in vitro Study

58.99 EUR
Development of Sustained Release Tablets of Eplerenone

Development of Sustained Release Tablets of Eplerenone

49.00 EUR
Process Optimization of Diclofenac Sodium Sustained Release Tablet: Dosage Form Development

Process Optimization of Diclofenac Sodium Sustained Release Tablet: Dosage Form Development

48.99 EUR